Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia
This article reviews the unique toxicities and adverse effects of blinatumomab and inotuzumab ozogamicin and provide recommendations for prevention of adverse effects as well as the management options for each medication.